Literatur
Zahn J, Wimmer S, Rödle W, Toni I, Sedlmayr B, Prokosch H‑U, Rascher W, Neubert A (2021) Development and Evaluation of a Web-Based Paediatric Drug Information System for Germany. Pharmacy 9:8. https://doi.org/10.3390/pharmacy9010008
Gore R, Chugh PK, Tripathi CD, Lhamo Y, Gautam S (2017) Pediatric off-label and unlicensed drug use and its implications. CCP 12:18–25. https://doi.org/10.2174/1574884712666170317161935
Bellis JR, Kirkham JJ, Thiesen S, Conroy EJ, Bracken LE, Mannix HL, Bird KA, Duncan JC, Peak M, Turner MA et al (2013) Adverse drug reactions and off-label and unlicensed medicines in children: a nested case-control study of inpatients in a pediatric hospital. BMC Med 11:238. https://doi.org/10.1186/1741-7015-11-238
van der Zanden TM, de Wildt SN, Liem Y, Offringa M, de Hoog M, Dutch Paediatric Pharmacotherapy Expertise Network N (2017) Developing a paediatric drug formulary for the Netherlands. Arch Dis Child 102:357–361
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
B. Erdlenbruch gibt an, dass kein Interessenkonflikt besteht.
Additional information
Redaktion
R. Kerbl, Leoben
G. Krandick, Oberhaching
T. Niehues, Krefeld
P. Voitl, Wien
Rights and permissions
About this article
Cite this article
Erdlenbruch, B. Mehr Sicherheit bei der Verordnung von Arzneimitteln für Kinder. Monatsschr Kinderheilkd 169, 395–397 (2021). https://doi.org/10.1007/s00112-021-01172-2
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00112-021-01172-2